Tag: our research

We’re proud to announce the latest recipients of our Future Leaders grants that’ve been awarded for their innovative new research projects.

Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.

Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.

Modern molecular profiling of medulloblastomas recently highlighted a previously unrecognised treatment benefit in a major international clinical trial.

A major UK trial of cannabis-based drug Sativex in treating the most aggressive form of brain tumour is to launch at 15 NHS hospitals, following promising results from a phase I study in 27 patients.

Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and, in lab studies working with model cell types, successfully reverse its effects to slow cancer cell growth with a targeted drug.

If we can find a way to interrupt a cancer cell’s ability to keep dividing, we may have a key to stopping tumours growing. Researchers, Dr Wong and Dr Voon ,tells us about the discovery they made into a tumour’s ability to continuously divide.

Research we funded has added value to a clinical trial that started in 2004. Updated scientific techniques showed that some children with a medulloblastoma can safely be spared harmful treatments.

We hear from two clinical psychologists who are helping young people after their brain tumour treatments through our ACT NOW study.

The Brian Cross Memorial Trust will fund ‘Future Leader’ Dr Spencer Watson’s three year glioblastoma brain tumour research.

New ‘Tessa Jowell Centre of Excellence’ status recognises delivery of outstanding care and treatment by NHS staff in their efforts to provide above excellent patient care through a difficult time

The Brain Tumour Charity responds to trial suggesting cannabis-based drug could be combined with chemotherapy in recurrent glioblastomas

We are calling on the Prime Minister to protect charity funded research – and we need your help!

The Oli Hilsdon Foundation pledges £1.5 million to fund a pioneering University College London research programme into brain tumours.

Neil and Angela Dickson have been named as the first recipients of a major global award from world leaders in the field.

Our researchers from The Everest Centre have new results that show the drug trametinib can stop tumour growth in some children with low grade brain tumours, in some cases the tumour was seen to shrink as well.

Across the board, support for our awareness and fundraising campaign is gathering pace

There was a huge outpouring of support for Tom Parker and his family, following his announcement across social media platforms on Monday of his brain tumour diagnosis.

The Nobel Prize for Chemistry 2020 has just been awarded to two female scientists, Emmanuelle Charpentier and Jennifer Doudna, for their work on developing the CRISPR/Cas9 gene editing technique.

Back in 2015 we launched our five year strategy ‘Defeating Brain Tumours’ and our research strategy ‘A Cure Can’t Wait’. Our manifestos were unashamedly ambitious, but we knew they had to be.

A new publication from one of our research projects shines a light on the differences between the cells in the middle/core of a glioblastoma (GBM) compared to the cells spreading/infiltrating into healthy brain around the tumour.

Dr Gelareh Zadeh is leading research in Canada which will help predict the risk of meningioma regrowth.

Many things are uncertain right now, but our commitment to research isn’t one of them.

The recent National Cancer Patient Experience Survey highlighted, once again, that those diagnosed with a brain tumour have one of the worst experiences of all cancer patients.